Daiichi Sankyo Co., Ltd.

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°CNet-Zero: Targets set

SBTI ID

40013042

Informations générales

Localisation

Japan

Asia

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

08/01/2026

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon FY2030

Statut

Targets set

Classification

1.5°C

Année cible

FY2030

Progression vers l'objectif0%
2015 (année de référence)FY2030
Objectifs à long terme (Long-Term)
Engagement de réduction des émissions à horizon FY2050

Statut

Targets set

Classification

1.5°C

Année cible

FY2050

Progression vers l'objectif0%
2015 (année de référence)FY2050
Description complète des objectifs

Overall Net-Zero Target: DAIICHI SANKYO CO.,LTD. commits to reach net-zero greenhouse gas emissions across the value chain by FY2050. Near-Term Targets: DAIICHI SANKYO CO.,LTD. commits to reduce absolute scope 1 and 2 GHG emissions 63% by FY2030 from a FY2015 base year. DAIICHI SANKYO CO.,LTD. Also commits to increase active annual sourcing of renewable electricity from 4.73% in FY2015 to 100% by FY2030. DAIICHI SANKYO CO.,LTD. further commits that 70.6% of its suppliers by emissions covering purchased goods and services, capital goods and upstream transportation and distribution, will have science-based targets by FY2030. Long-Term Targets: DAIICHI SANKYO CO.,LTD. commits to reduce absolute scope 1 and 2 GHG emissions 90.00% by FY2040 from a FY2015 base year. DAIICHI SANKYO CO.,LTD. commits to reduce absolute scope 3 GHG emissions 90.00% by FY2050 from a FY2020 base year.

Net-Zero

Statut

Targets set

Année cible

FY2050

Progression0%
Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Identifiants

ISIN

JP3475350009

LEI

353800XGIU2IHQGC9504

Source : Science Based Targets initiative | Données publiques